Effect of the single administration of functional carbohydrate on plasma biomarkers
Not Applicable
Completed
- Conditions
- Borderline diabetic: Screened based on fasting blood glucose levels from 110 mg/dl and below 126 mg/dl, or HbA1c(NGSP) levels from 6.2% and below 6.5%.High LDL-C subject: LDL-C levels from 120 mg/dl and below 160 mg/dl.
- Registration Number
- JPRN-jRCT1090220244
- Lead Sponsor
- Matsutani Chemical Industry Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 14
Inclusion Criteria
Borderline diabetic: Screened based on fasting blood glucose levels from 110 mg/dl and below 126 mg/dl, or HbA1c(NGSP) levels from 6.2% and below 6.5%.
High LDL-C subject: LDL-C levels from 120 mg/dl and below 160 mg/dl.
Exclusion Criteria
1. Individuals suffering from serious diseases
2. Individuals had intestinal surgeries
3. Individuals using medications to control blood glucose and lipid levels
4. Individuals how are allergic to oligosaccharides and sweeteners
5. Individuals using functional foods to control blood glucose and lipid levels
6. Individuals participate in other clinical trials (food material, medicine, cosmetics, liniment)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum lipids of up to 24 hours after ingestion (triglyceride, cholesterol, apoprotein)
- Secondary Outcome Measures
Name Time Method Blood glucose and insulin levels of up to 24 hours after ingestion